ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
์ข
๋ชฉ ์ฝ๋ ICUI
ํ์ฌ ์ด๋ฆICU Medical Inc
์์ฅ์ผMar 31, 1992
CEOJain (Vivek)
์ง์ ์15000
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃMar 31
์ฃผ์951 Calle Amanecer
๋์SAN CLEMENTE
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ92673-6212
์ ํ19493662183
์น์ฌ์ดํธhttps://www.icumed.com/
์ข
๋ชฉ ์ฝ๋ ICUI
์์ฅ์ผMar 31, 1992
CEOJain (Vivek)
์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.

๋ฐ์ดํฐ ์์